Literature DB >> 9099927

IL-10-driven immunoglobulin production by B lymphocytes from IgA-deficient individuals correlates to infection proneness.

V Friman1, L A Hanson, J M Bridon, A Tarkowski, J Banchereau, F Brière.   

Abstract

In search for a possible explanation of the phenotypic heterogeneity in IgA deficiency, we studied the function of B cells from IgA-deficient (IgAd) individuals. Two groups of IgAd individuals, one frequently infected and one clinically apparently healthy, as well as normal controls, were studied. Peripheral blood mononuclear cells (PBMC) and B cells from IgAd individuals and controls were cultured with Staphylococcus aureus Cowan I strain and with anti-CD40 MoAb presented on the CD32-transfected fibroblast cell line in the presence of IL-10. In this experimental system PBMC and B cells from the infection-prone IgAd individuals produced only minute amounts of IgA. In contrast, PBMC and B cells from healthy IgAd subjects secreted significantly more IgA1 and IgA2 in comparison with infection-prone IgAd patients (P < 0.05). These data suggest that the abnormalities of B cell differentiation in IgAd could be of heterogeneous origin. Thus, whereas in healthy IgAd subjects IgA production may be efficiently up-regulated in vitro by addition of IL-10 to CD40-activated B cell culture, the corresponding B cell differentiation does not occur in infection-prone IgAd patients. These observations provide a conceptual framework for phenotypic heterogeneity in IgAd subjects.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 9099927      PMCID: PMC2200449          DOI: 10.1046/j.1365-2249.1996.38746.x

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  4 in total

Review 1.  Selective IgA deficiency (SIgAD) and common variable immunodeficiency (CVID).

Authors:  L Hammarström; I Vorechovsky; D Webster
Journal:  Clin Exp Immunol       Date:  2000-05       Impact factor: 4.330

2.  IL-10 and IL-4 co-operate to normalize in vitro IgA production in IgA-deficient (IgAD) patients.

Authors:  M Marconi; A Plebani; M A Avanzini; R Maccario; A Pistorio; M Duse; M Stringa; V Monafo
Journal:  Clin Exp Immunol       Date:  1998-06       Impact factor: 4.330

Review 3.  Physiology of IgA and IgA deficiency.

Authors:  C Cunningham-Rundles
Journal:  J Clin Immunol       Date:  2001-09       Impact factor: 8.317

4.  Primary antibody deficiency in Arabs: first report from eastern Saudi Arabia.

Authors:  R A al-Attas; A H Rahi
Journal:  J Clin Immunol       Date:  1998-09       Impact factor: 8.317

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.